Cargando…
Disease Assessment in Psoriasis
Researchers are making all out efforts worldwide, to find a serological marker to monitor the disease severity and/or measure efficacy of the drug. There are many potential molecular targets being investigated as a candidate marker. However, till date there has been no significant breakthrough. Thus...
Autores principales: | Manchanda, Yashpal, De, Abhishek, Das, Sudip, Chakraborty, Disha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389140/ https://www.ncbi.nlm.nih.gov/pubmed/37529444 http://dx.doi.org/10.4103/ijd.ijd_420_23 |
Ejemplares similares
-
Biologics and Biosimilars in Psoriasis
por: Ahmed, Sk Shahriar, et al.
Publicado: (2023) -
Topical Therapy in Psoriasis
por: Ahmed, SK Shahriar, et al.
Publicado: (2023) -
Psoriasis: A Dermatological Enigma
por: Das, Sudip, et al.
Publicado: (2022) -
Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018) -
Impact of Psoriasis on Quality of Life
por: Agarwal, Komal, et al.
Publicado: (2022)